Many studies have demonstrated that the presence of PD-1+ tumor-infiltrating lymphocytes and PD-L1+ microglial cells, tumor-associated macrophages, and tumor cells within the TME correlate with patient outcomes. Here, CD274 is linked to neoplasm.